Agency Information Collection Activities; Proposed eCollection, eComments Requested; Revision of a Currently Approved Collection; the National Forensic Laboratory Information System Collection of Drug Analysis Data, 38324-38325 [2018-16740]

Download as PDF 38324 Federal Register / Vol. 83, No. 151 / Monday, August 6, 2018 / Notices DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Cooperative Research Group on ROS-Industrial Consortium Americas Notice is hereby given that, on July 12, 2018, Pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Southwest Research Institute—Cooperative Research Group on ROS-Industrial Consortium-Americas (‘‘RIC-Americas’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Microsoft Corp., Redmond, WA, has been added as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and RIC-Americas intends to file additional written notifications disclosing all changes in membership. On April 30, 2014, RIC-Americas filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on June 9, 2014 (79 FR 32999). The last notification was filed with the Department on June 11, 2018. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on July 9, 2018 (83 FR 31775). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2018–16713 Filed 8–3–18; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE sradovich on DSK3GMQ082PROD with NOTICES Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Integrated Photonics Institute for Manufacturing Innovation Operating Under the Name of The American Institute for Manufacturing Integrated Photonics National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Integrated Photonics Institute for Manufacturing Innovation operating under the name of the American Institute for Manufacturing Integrated Photonics (‘‘AIM Photonics’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Applied Materials, Inc., Santa Clara, CA; The Board of Governors of the Colorado State University System acting by and through Colorado State University, Fort Collins, CO; Stonehill College, Inc., Easton, MA; University of Chicago Argonne LLC, as operator of Argonne National Laboratory, Lemont, IL; The George Washington University, Washington, DC; Marktech International Corporation dba Marktech Optoelectronics, Latham, NY; and Israeli Hi-Tech Association at the Manufacturer’s Association of Israel, TelAviv, ISRAEL, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and AIM Photonics intends to file additional written notifications disclosing all changes in membership. On June 16, 2016, AIM Photonics filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on July 25, 2016 (81 FR 48450). The last notification was filed with the Department on January 26, 2018. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on March 12, 2018 (83 FR 10750). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2018–16706 Filed 8–3–18; 8:45 am] BILLING CODE 4410–11–P Notice is hereby given that, on July 23, 2018, pursuant to Section 6(a) of the VerDate Sep<11>2014 17:36 Aug 03, 2018 Jkt 244001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE [OMB Number 1117–0034] Agency Information Collection Activities; Proposed eCollection, eComments Requested; Revision of a Currently Approved Collection; the National Forensic Laboratory Information System Collection of Drug Analysis Data Drug Enforcement Administration, Department of Justice. ACTION: 30-day Notice. AGENCY: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection was previously published in the Federal Register, on June 11, 2018, allowing for a 60 day comment period. DATES: Comments are encouraged and will be accepted for 30 days until September 5, 2018. FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Thomas D. Sonnen, Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598–6812 or sent to OIRA_submission@omb.eop.gov. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of SUMMARY: E:\FR\FM\06AUN1.SGM 06AUN1 Federal Register / Vol. 83, No. 151 / Monday, August 6, 2018 / Notices sradovich on DSK3GMQ082PROD with NOTICES appropriate automated, electronic, mechanical, or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection 1. Type of Information Collection: Revision of a currently approved collection. 2. Title of the Form/Collection: The National Forensic Laboratory Information System Collection of Drug Analysis Data. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: Medical Examiner/Coroner Office Survey; National Forensic Laboratory Information System Drug Survey of Drug Laboratories; and Toxicology Laboratory Survey for the component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Forensic Science Laboratory Management. Abstract: The National Forensic Laboratory Information System (NFLIS) collections provide the DEA with national databases on analyzed drug samples from law enforcement activities, antemortem toxicology samples (toxiciology laboratories), and post-mortem toxicology samples (medical examiner/coroner offices (MECs) from federal, state, and local laboratories. Specifically, NFLIS-Drug data provide DEA current, precise, and representative estimates of drugs seized by law enforcement and analyzed by forensic laboratories. Since 2001, DEA has had case and drug report estimates for all drugs reported in NFLIS that are statistically representative of the nation and of census regions. The estimates, which are made possible by updating the laboratory profiles through the survey effort (see draft survey in Appendix), have given DEA the ability to track national and regional drug trends; a clearer national picture of illicit or diverted drug availability; additional information about the temporal changes in drug availability by geographic region; and the ability to detect new or emerging drugs. Information from NFLIS is combined with other existing databases to develop more accurate, up-to-date information on abused drugs. This database represents a voluntary, cooperative effort on the part of participating laboratories and MECs to provide a centralized source of analyzed drug VerDate Sep<11>2014 17:36 Aug 03, 2018 Jkt 244001 data. Existing federal drug abuse databases do not provide the type, scope, timeliness, or quality of information necessary to effectively estimate the actual or relative abuse potential of drugs as required under the Controlled Substances Act (21 U.S.C. 811(b)) and international treaties in a timely and efficient manner. For example, much of the trafficking data for federal drug scheduling actions is presently obtained on a case-by-case basis from state and local laboratories. Occasionally scientific personnel from the DEA’s Diversion Control Division, Drug and Chemical Evaluation Section, have contacted specific laboratories and requested files. In addition, some DEA field offices routinely subpoena MEC records for use in case work. The development of the National Forensic Laboratory Information System (NFLIS) greatly enhances the collection of such data. Submission of information for this collection is voluntary. DEA is not mandating this information collection. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The DEA estimates that 140 persons annually for this collection at 1.6 hour per respondent, for an annual burden of 218 hours. 6. An estimate of the total public burden (in hours) associated with the proposed collection: The DEA estimates that this collection takes 218 annual burden hours. If additional information is required please contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC 20530. Dated: August 1, 2018. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2018–16740 Filed 8–3–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [OMB Number 1121–NEW] Agency Information Collection Activities; Proposed eCollection eComments Requested; New Collection: Survey of State Attorneys General Offices (SSAGO): Human Trafficking Bureau of Justice Statistics, Department of Justice. ACTION: 60-Day notice. AGENCY: PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 38325 The Department of Justice (DOJ), Office of Justice Programs, Bureau of Justice Statistics (BJS), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 60 days until October 5, 2018. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Suzanne Strong, Statistician, Prosecution and Judicial Statistics Unit, Bureau of Justice Statistics, 810 Seventh Street NW, Washington, DC 20531 (email: Suzanne.M.Strong@usdoj.gov; telephone: 202–616–3666). SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. SUMMARY: Overview of This Information Collection (1) Type of Information Collection: New collection. (2) The Title of the Form/Collection: Survey of State Attorneys General Offices (SSAGO)—Human Trafficking. (3) The agency form number, if any, and the applicable component of the Department sponsoring the collection: SSAGO–2. The applicable component E:\FR\FM\06AUN1.SGM 06AUN1

Agencies

[Federal Register Volume 83, Number 151 (Monday, August 6, 2018)]
[Notices]
[Pages 38324-38325]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16740]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0034]


Agency Information Collection Activities; Proposed eCollection, 
eComments Requested; Revision of a Currently Approved Collection; the 
National Forensic Laboratory Information System Collection of Drug 
Analysis Data

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-day Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice (DOJ), Drug Enforcement 
Administration (DEA), will be submitting the following information 
collection request to the Office of Management and Budget (OMB) for 
review and approval in accordance with the Paperwork Reduction Act of 
1995. The proposed information collection was previously published in 
the Federal Register, on June 11, 2018, allowing for a 60 day comment 
period.

DATES: Comments are encouraged and will be accepted for 30 days until 
September 5, 2018.

FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated 
public burden or associated response time, suggestions, or need a copy 
of the proposed information collection instrument with instructions or 
additional information, please contact Thomas D. Sonnen, Diversion 
Control Division, Drug Enforcement Administration; Mailing Address: 
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 
598-6812 or sent to [email protected].

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of

[[Page 38325]]

appropriate automated, electronic, mechanical, or other forms of 
information technology, e.g., permitting electronic submission of 
responses.

Overview of This Information Collection

    1. Type of Information Collection: Revision of a currently approved 
collection.
    2. Title of the Form/Collection: The National Forensic Laboratory 
Information System Collection of Drug Analysis Data.
    3. The agency form number, if any, and the applicable component of 
the Department sponsoring the collection: Medical Examiner/Coroner 
Office Survey; National Forensic Laboratory Information System Drug 
Survey of Drug Laboratories; and Toxicology Laboratory Survey for the 
component within the Department of Justice is the Drug Enforcement 
Administration, Diversion Control Division.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Forensic Science Laboratory Management.
    Abstract: The National Forensic Laboratory Information System 
(NFLIS) collections provide the DEA with national databases on analyzed 
drug samples from law enforcement activities, antemortem toxicology 
samples (toxiciology laboratories), and post-mortem toxicology samples 
(medical examiner/coroner offices (MECs) from federal, state, and local 
laboratories. Specifically, NFLIS-Drug data provide DEA current, 
precise, and representative estimates of drugs seized by law 
enforcement and analyzed by forensic laboratories. Since 2001, DEA has 
had case and drug report estimates for all drugs reported in NFLIS that 
are statistically representative of the nation and of census regions. 
The estimates, which are made possible by updating the laboratory 
profiles through the survey effort (see draft survey in Appendix), have 
given DEA the ability to track national and regional drug trends; a 
clearer national picture of illicit or diverted drug availability; 
additional information about the temporal changes in drug availability 
by geographic region; and the ability to detect new or emerging drugs. 
Information from NFLIS is combined with other existing databases to 
develop more accurate, up-to-date information on abused drugs. This 
database represents a voluntary, cooperative effort on the part of 
participating laboratories and MECs to provide a centralized source of 
analyzed drug data. Existing federal drug abuse databases do not 
provide the type, scope, timeliness, or quality of information 
necessary to effectively estimate the actual or relative abuse 
potential of drugs as required under the Controlled Substances Act (21 
U.S.C. 811(b)) and international treaties in a timely and efficient 
manner. For example, much of the trafficking data for federal drug 
scheduling actions is presently obtained on a case-by-case basis from 
state and local laboratories. Occasionally scientific personnel from 
the DEA's Diversion Control Division, Drug and Chemical Evaluation 
Section, have contacted specific laboratories and requested files. In 
addition, some DEA field offices routinely subpoena MEC records for use 
in case work. The development of the National Forensic Laboratory 
Information System (NFLIS) greatly enhances the collection of such 
data. Submission of information for this collection is voluntary. DEA 
is not mandating this information collection.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
that 140 persons annually for this collection at 1.6 hour per 
respondent, for an annual burden of 218 hours.
    6. An estimate of the total public burden (in hours) associated 
with the proposed collection: The DEA estimates that this collection 
takes 218 annual burden hours.
    If additional information is required please contact: Melody 
Braswell, Department Clearance Officer, United States Department of 
Justice, Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC 
20530.

    Dated: August 1, 2018.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2018-16740 Filed 8-3-18; 8:45 am]
 BILLING CODE 4410-09-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.